0001104659-20-031954.txt : 20200311 0001104659-20-031954.hdr.sgml : 20200311 20200311163036 ACCESSION NUMBER: 0001104659-20-031954 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200311 DATE AS OF CHANGE: 20200311 EFFECTIVENESS DATE: 20200311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-362571 FILM NUMBER: 20705645 BUSINESS ADDRESS: STREET 1: 24 WEST 40TH STREET STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 24 WEST 40TH STREET STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 D 1 primary_doc.xml X0708 D LIVE 0001541157 Akari Therapeutics Plc 75/76 WIMPOLE STREET LONDON X0 UNITED KINGDOM W1G 9RT +44 20 8004 0270 UNITED KINGDOM None Celsus Therapeutics Plc. Morria Biopharmaceuticals PLC Corporation true Clive Richardson c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Executive Officer Director Peter Feldschreiber c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Director Ray Prudo c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Director James Hill c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Director Stuart Ungar c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Director David Byrne c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Director Donald Williams c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Director Michael Grissinger c/o Akari Therapeutics, PLC 75/76 Wimpole Street London X0 UNITED KINGDOM W1G 9RT Director Biotechnology Decline to Disclose 06b false 2020-02-13 false true true false 0 Paulson Investment Company, LLC 5670 None None 2141 W. NORTH AVE. 2ND FLOOR CHICAGO IL ILLINOIS 60647 CA CALIFORNIA CT CONNECTICUT FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA MD MARYLAND MI MICHIGAN NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA TX TEXAS VA VIRGINIA WI WISCONSIN WY WYOMING true 9554528 9554528 0 false 53 764362 0 449,623 placement agent warrants 0 Working capital purposes false Akari Therapeutics Plc /s/ Clive Richardson Clive Richardson Chief Executive Officer and Chief Operating Officer 2020-03-11